Daiwa Securities Group
IMA

Daiwa Securities Group’s ImageneBio Inc IMA Stock Holding History

Daiwa Securities Group’s Portfolio IMA Stock Details IMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-9
Closed – – 1340
2022
Q3 		$0 Hold
9
– – ﹤0.01% 1360
2022
Q2 		$0 Hold
9
– – ﹤0.01% 1388
2022
Q1 		$1K Hold
9
– – ﹤0.01% 1311
2021
Q4 		$1K Buy
+9
New +$1.46K ﹤0.01% 1338

Other funds holding IMA

AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Daiwa Securities Group's IMA Position: Q4 2022 in Review

Daiwa Securities Group sold out of ImageneBio Inc (IMA) in Q4 2022, closing a stake of 9 shares.

Daiwa Securities Group first reported a position in IMA in Q4 2021 and held it in 4 quarters. The position peaked at $1K in Q1 2022. 34 funds tracked by Wall St. Rank hold IMA as of Q4 2022.

  • Daiwa Securities Group reported no remaining ImageneBio Inc position as of Q4 2022 after selling out during the quarter.
  • Daiwa Securities Group sold 9 ImageneBio Inc shares in Q4 2022.
  • Daiwa Securities Group first reported a position in ImageneBio Inc in Q4 2021 and held it in 4 quarters.
  • Daiwa Securities Group's ImageneBio Inc position peaked at $1K in Q1 2022.
  • 34 funds tracked by Wall St. Rank held ImageneBio Inc as of Q4 2022.

Based on Daiwa Securities Group's 13F filing for Q4 2022, filed 6 Feb 2023.